ABSTRACT:The metabolism of methoxychlor, a proestrogenic pesticide (endocrine disruptor), was investigated with cDNA expressed human cytochrome P450s and liver microsomes (HLM). In addition to 1,1,1-trichloro-2-(4-hydroxyphenyl)-2-(4-methoxyphenyl)ethane (mono-OH-M), 1,1,1-trichloro-2, 2-bis(4-hydroxyphenyl)ethane (bis-OH-M), and 1,1,1-trichloro-2-(4-hydroxyphenyl)-2-(3, 4-dihydroxyphenyl)ethane (tris-OH-M), a new metabolite was identified as 1,1,1- Methoxychlor, 1 a biodegradable pesticide and a substitute for the banned DDT, has a relatively low toxicity and short half-life (Metcalf et al., 1971;Gardner and Bailey, 1975;Metcalf, 1976). Despite these favorable features of methoxychlor, there is considerable concern for exposure to methoxychlor because of its estrogenic activity (Bulger et al., 1978b;Ousterhout et al., 1981). Whereas in vitro methoxychlor has little or no affinity for the estrogen receptor (ER), in vivo methoxychlor exhibits pronounced estrogenic activity, indicating that methoxychlor per se is a proestrogen (Bulger et al., 1978a,b;Kupfer and Bulger, 1979;Bulger et al., 1985). Indeed, methoxychlor undergoes oxidative metabolism by hepatic cytochrome P450 forming metabolites with pronounced estrogenic activity (Bulger et al., 1978a,b;Bulger et al., 1985). Additionally, methoxychlor was found to elicit considerable endocrine and reproductive toxicity (Gray et al., 1988;Cummings and Gray, 1989;Cummings and Laskey, 1993). However, hitherto it has not been established whether the endocrine and reproductive toxicities are associated with methoxychlor per se or are primarily due to its metabolites. Based on such and other findings, methoxychlor was categorized as a prototype endocrine disruptor, and the nature of its toxicity has been under protracted intensive investigation (Chapin et al., 1997;Cummings, 1997;You et al., 2002). Interestingly, the mono-and bis-demethylated methoxychlor metabolites (mono-OH-M and bis-OH-M) exhibit opposing activities toward the ER␣ and ER isoforms [i.e., both metabolites are agonists of ER␣, but antagonists of ER, as well as antagonists of the androgen receptor (Gaido et al., 2000)]. Additionally, it was reported that bis-OH-M activity differs considerably from that of estradiol-17 in affecting certain gene expression in mice ovaries (Waters et al., 2001), possibly explaining the distinctive but overlapping pathologies in
trichloro-2-(4-methoxyphenyl)-2-(3, 4-dihydroxyphenyl)ethane (catechol-M; previously assumed to be ring-OH-M) and as a key metabolic intermediate. A novel metabolic route was proposed involving methoxychlor O-demethylation to mono-OH-M, followed by bifurcation of the pathway, both leading to the same final product tris-OH-M: pathway a, mono-OH-M is demethylated to bis-OH-M, followed by ortho-hydroxylation forming tris-OH-M and pathway b, mono-OH-M is ortho-hydroxylated forming catechol-M that is O-demethylatedThe project described was supported by an National Institutes of Health Grant ES00834 from the National Institute of Environmental Health Sci...